2020
DOI: 10.46459/pmu.2020010
|View full text |Cite
|
Sign up to set email alerts
|

Current achievements and future perspectives with liquid biopsy

Abstract: Liquid biopsy with circulating tumor DNA (ctDNA) has become widely applied in clinical settings in step with progress in innovative technologies. Since circulating free DNA (cfDNA) was found in human plasma from patients with various cancers as well as auto-immune diseases, clinical application to oncology has spread, especially involving molecular analysis. cfDNA contains ctDNA derived from cancer cells, and it is not possible to isolate ctDNA from cfDNA derived from normal cells. Therefore, we need to recogn… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 51 publications
(72 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?